Connect with us

Cannabis

New York Continues To Struggle With Legal Weed

Published

on


One of the most liberal and populous and visited cities in the US, yet New York continues to struggle with legal weed

The Big Apple has some amazing things including The Metropolitan Museum, condos worth $75+ million, delis sandwiches to make your heart sing and a creative community like none other.  But it seems they can’t pull their act together to sell marijuana.  New York continues to struggle with legal weed, but they are trying to put a positive spin on it.

Cannabis has been legal for medical purposes under New York law since 2016, and recreational purposes since 2021. But thanks to state workers, New York is being robbed of hundreds of millions of dollars of revenue due to the way they rolled out legalization. New York laid out a clear pathway including a way for medical dispensaries to flip to fully legal, then, at the last minute, scrapped it all and went with a total different version.  Now a lack of clear and timely regulations, and a complex application process has lead to less than a 100 legal dispensaries open, but over 1,500 unlicensed open in New York City alone.

RELATED: Science Says Medical Marijuana Improves Quality Of Life

The New York Office of Cannabis Management is looking to allow 100 new legal licenses, after only a few months of debating. But the bureaucrats in New York has an answer to make really only another small portion happy – allow more home grow!  They acknowledge they can’t really police the majority of unlicensed retailers making millions, so lets focus on the few home growers will will never really look at.

It hasn’t be clear about home grow in the state, but it is becoming more clear now. For the home cultivation regulations, which were developed by the Office of Cannabis Management and submitted to Cannabis Control Board, the approved resolution means there will now be a 60-day public comment period before the rules are finalized.  For the older, traditional consumer population, this is somewhat good news.  For the majority of consumers. it means nada.

When looking at research from BDSA, a leading cannabis data analyst firm, vapes and gummies are the most popular, especially for the under 40 set. Specifically, 49% of consumers across adult-use and medical states claimed to have consumed a gummy edible in the past six months compared to 47% who used flower.

For a comparison, The latest Gallup research find 37% of people drink beer as their primary alcohol. This is compared to 17% who use all forms of marijuana. The Brewers Association, a national group that holds regular conferences and competitions, estimated despite the massive amount of beer drinkers, only about 1.1 million try to make it home.

RELATED: The Most Popular Marijuana Flavors

Neighboring state New Jersey, not know for outshining New York State, excels in legal marijuana.  The state is on track to break $1 billion in annual sales and will be a boom for state tax revenues. You know it is rough when Curbed does a guide for “legal dispensaries” in NYC so you have some guidance.



Source link

Cannabis

White House Finally Comments On Marijuana Industry

Published

on

By


Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.

The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster.  With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes.  Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.

RELATED: Music Is A Turn On Like Sex And Marijuana

The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.

During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.

The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.

The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.

RELATED: The Science Behind Why Music Sounds So Much Better When You’re High

While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.



Source link

Continue Reading

Cannabis

This State’s Cannabis Revenue Keeps Pouring In

Published

on

By


States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.

The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.

RELATED: Mike Johnson And Marijuana

“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”

Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds.  Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.

States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.

In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.

RELATED: Marijuana Use And Guy’s Member

Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.

The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.

This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.



Source link

Continue Reading

Cannabis

Mixed Messages From The Feds About Cannabis

Published

on

By


The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.

The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses.  Millions use medical marijuana for health issues ranging from chronic pain to sleep.  But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.

RELATED: Music Is A Turn On Like Sex And Marijuana

The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.

Photo by yavdat/Getty Images

The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.

Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.

RELATED: The Science Behind Why Music Sounds So Much Better When You’re High

In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.

This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media